File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41556-019-0333-2
- Scopus: eid_2-s2.0-85066957043
- PMID: 31160711
- WOS: WOS:000470080100006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Establishment of porcine and human expanded potential stem cells
Title | Establishment of porcine and human expanded potential stem cells |
---|---|
Authors | Gao, XNowak-Imialek, MChen, XChen, DHerrmann, DRuan, DChen, ACHEckersley-Maslin, MAAhmad, SLee, YLKobayashi, TRyan, DZhong, JZhu, JWu, JLan, GPetkov, SYang, JAntunes, LCampos, LSFu, BWang, SYong, YWang, XXue, SGGe, LLiu, ZHuang, YNie, TLi, PWu, DPei, DZhang, YLu, LYang, FKimber, SJReik, WZou, XShang, ZLai, LSurani, ATam, PPLAhmed, AYeung, WSBTeichmann, SANiemann, HLiu, P |
Keywords | biotechnology chimera embryo gene editing gene expression |
Issue Date | 2019 |
Publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/naturecellbiology |
Citation | Nature Cell Biology, 2019, v. 21 n. 6, p. 687-699 How to Cite? |
Abstract | We recently derived mouse expanded potential stem cells (EPSCs) from individual blastomeres by inhibiting the critical molecular pathways that predispose their differentiation. EPSCs had enriched molecular signatures of blastomeres and possessed developmental potency for all embryonic and extra-embryonic cell lineages. Here, we report the derivation of porcine EPSCs, which express key pluripotency genes, are genetically stable, permit genome editing, differentiate to derivatives of the three germ layers in chimeras and produce primordial germ cell-like cells in vitro. Under similar conditions, human embryonic stem cells and induced pluripotent stem cells can be converted, or somatic cells directly reprogrammed, to EPSCs that display the molecular and functional attributes reminiscent of porcine EPSCs. Importantly, trophoblast stem-cell-like cells can be generated from both human and porcine EPSCs. Our pathway-inhibition paradigm thus opens an avenue for generating mammalian pluripotent stem cells, and EPSCs present a unique cellular platform for translational research in biotechnology and regenerative medicine. |
Persistent Identifier | http://hdl.handle.net/10722/287592 |
ISSN | 2023 Impact Factor: 17.3 2023 SCImago Journal Rankings: 8.913 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gao, X | - |
dc.contributor.author | Nowak-Imialek, M | - |
dc.contributor.author | Chen, X | - |
dc.contributor.author | Chen, D | - |
dc.contributor.author | Herrmann, D | - |
dc.contributor.author | Ruan, D | - |
dc.contributor.author | Chen, ACH | - |
dc.contributor.author | Eckersley-Maslin, MA | - |
dc.contributor.author | Ahmad, S | - |
dc.contributor.author | Lee, YL | - |
dc.contributor.author | Kobayashi, T | - |
dc.contributor.author | Ryan, D | - |
dc.contributor.author | Zhong, J | - |
dc.contributor.author | Zhu, J | - |
dc.contributor.author | Wu, J | - |
dc.contributor.author | Lan, G | - |
dc.contributor.author | Petkov, S | - |
dc.contributor.author | Yang, J | - |
dc.contributor.author | Antunes, L | - |
dc.contributor.author | Campos, LS | - |
dc.contributor.author | Fu, B | - |
dc.contributor.author | Wang, S | - |
dc.contributor.author | Yong, Y | - |
dc.contributor.author | Wang, X | - |
dc.contributor.author | Xue, SG | - |
dc.contributor.author | Ge, L | - |
dc.contributor.author | Liu, Z | - |
dc.contributor.author | Huang, Y | - |
dc.contributor.author | Nie, T | - |
dc.contributor.author | Li, P | - |
dc.contributor.author | Wu, D | - |
dc.contributor.author | Pei, D | - |
dc.contributor.author | Zhang, Y | - |
dc.contributor.author | Lu, L | - |
dc.contributor.author | Yang, F | - |
dc.contributor.author | Kimber, SJ | - |
dc.contributor.author | Reik, W | - |
dc.contributor.author | Zou, X | - |
dc.contributor.author | Shang, Z | - |
dc.contributor.author | Lai, L | - |
dc.contributor.author | Surani, A | - |
dc.contributor.author | Tam, PPL | - |
dc.contributor.author | Ahmed, A | - |
dc.contributor.author | Yeung, WSB | - |
dc.contributor.author | Teichmann, SA | - |
dc.contributor.author | Niemann, H | - |
dc.contributor.author | Liu, P | - |
dc.date.accessioned | 2020-10-05T12:00:20Z | - |
dc.date.available | 2020-10-05T12:00:20Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Nature Cell Biology, 2019, v. 21 n. 6, p. 687-699 | - |
dc.identifier.issn | 1465-7392 | - |
dc.identifier.uri | http://hdl.handle.net/10722/287592 | - |
dc.description.abstract | We recently derived mouse expanded potential stem cells (EPSCs) from individual blastomeres by inhibiting the critical molecular pathways that predispose their differentiation. EPSCs had enriched molecular signatures of blastomeres and possessed developmental potency for all embryonic and extra-embryonic cell lineages. Here, we report the derivation of porcine EPSCs, which express key pluripotency genes, are genetically stable, permit genome editing, differentiate to derivatives of the three germ layers in chimeras and produce primordial germ cell-like cells in vitro. Under similar conditions, human embryonic stem cells and induced pluripotent stem cells can be converted, or somatic cells directly reprogrammed, to EPSCs that display the molecular and functional attributes reminiscent of porcine EPSCs. Importantly, trophoblast stem-cell-like cells can be generated from both human and porcine EPSCs. Our pathway-inhibition paradigm thus opens an avenue for generating mammalian pluripotent stem cells, and EPSCs present a unique cellular platform for translational research in biotechnology and regenerative medicine. | - |
dc.language | eng | - |
dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/naturecellbiology | - |
dc.relation.ispartof | Nature Cell Biology | - |
dc.rights | This is a post-peer-review, pre-copyedit version of an article published in [insert journal title]. The final authenticated version is available online at: https://doi.org/[insert DOI] | - |
dc.subject | biotechnology | - |
dc.subject | chimera | - |
dc.subject | embryo | - |
dc.subject | gene editing | - |
dc.subject | gene expression | - |
dc.title | Establishment of porcine and human expanded potential stem cells | - |
dc.type | Article | - |
dc.identifier.email | Ruan, D: degong77@hku.hk | - |
dc.identifier.email | Wu, J: jackng83@hku.hk | - |
dc.identifier.email | Liu, P: pliu88@hku.hk | - |
dc.identifier.authority | Liu, P=rp02328 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1038/s41556-019-0333-2 | - |
dc.identifier.pmid | 31160711 | - |
dc.identifier.pmcid | PMC7035105 | - |
dc.identifier.scopus | eid_2-s2.0-85066957043 | - |
dc.identifier.hkuros | 315739 | - |
dc.identifier.volume | 21 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 687 | - |
dc.identifier.epage | 699 | - |
dc.identifier.isi | WOS:000470080100006 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1465-7392 | - |